0%
Some breaking news from Oklahoma’s bioscience community: Oklahoma companies Moleculera Labs and Lipid Biologics are among a select few chosen to make their pitch to potential investors in Startup Stadium competition at the upcoming BIO show June 4-7 in Boston. Congratulations!Read more
Copyright © 2017, The Oklahoma Publishing Co. Oklahoma City’s Moleculera Labs Inc., an autoimmune neurobiology company, said Monday that a key patent has been issued covering the company’s method of identifying whether someone’s neurologic or psychiatric symptoms could be caused by an autoimmune dysfunction. The patent covers Moleculera’s methods of diagnosing pediatric acute-onset neuropsychiatric syndromeRead more
By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. In his second book, “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies,” Craig Shimasaki, Ph.D., titles one section “Learning from Failure.” “Failure is not a person or way of life; failure is an event,” Shimasaki said. “Interestingly, you learn immeasurably more from things that don’tRead more
For OU graduate student Amanda Curtis, the 2016 BIO show required some unique multi-tasking skills. Curtis greeted visitors to the Oklahoma exhibition booth, participated in Oklahoma Bioscience networking events and sat in on multiple partnering meetings with her colleagues from OU’s Office of Technology Development. All in a day’s work.
Increasing evidence points to a relationship between certain bacterial infections and autoimmune attacks that can disrupt normal neurologic functioning, according to researchers at Moleculera Labs. Using a panel of biomarker tests for autoantibodies against specific neuronal antigens and a key enzyme involved in the upregulation of many neurotransmitters can help physicians better diagnose and treat the underlying cause of such conditions, which are often misdiagnosed as psychiatric illnesses, motor tics or autism spectrum disorders and treated inappropriately with psychotropic drugs.
A decade ago, Dr. Michael Centola, an Oklahoma medical researcher had an idea to assess the genomic makeup of millions of people who suffer from an inflammatory disease known as rheumatoid arthritis. Then a scientist at the Oklahoma Medical Research Foundation (OMRF), Dr. Centola founded Riley Genomic and based its operations at the Presbyterian HealthRead more
By Journal Record Staff Copyright © 2015 The Journal Record OKLAHOMA CITY – Moleculera Labs Inc. has received renewal of Commission on Office Laboratories Accreditation certification. The company’s testing services are licensed in 49 states, with licensure in New York state pending. The Moleculera tests, known collectively as the Cunningham Panel, help physicians determine whether theRead more
By staff writers Courtesy of The Journal Record OKLAHOMA CITY – Moleculera Labs has been awarded a two-year $300,000 matching grant from the Oklahoma Center for the Advancement of Science and Technology. The grant supports the development and clinical validation of new diagnostic testing panels to identify autoantibodies directed against neuronal antigens in patients experiencingRead more
Copyright © 2015, The Oklahoma Publishing Company Moleculera Labs Inc. recently received a $1.06 million investment from i2E Inc., angel investors and others. Nonprofit corporation i2E Inc. recently led a $1.06 million investment in Oklahoma City-based Moleculera Labs Inc., through its Accelerate Oklahoma! fund. The funding of $530,000 from i2E was half of the investmentRead more
